We have put together a map showing the distribution of GIST patients in the U.S. who are living with GIST in the LRG Patient Registry by state. The map shows how geographically diverse the Patient Registry is, with patients spread throughout the country.
The LRG is continually involved in advocacy efforts to increase government spending on cancer research. We have joined forces with other cancer agencies to once again urge New Jersey Governor Chris Christie and the New [...]
Larry Ryan was born in Brooklyn, New York, on September 25, 1945; he passed from this world into the loving arms of Christ on February 25, 2013.
Join our Tissue Bank - Help the LRG in the search for a cure. Wildtype GIST tissue is needed for a current LRG Research Team project. If you or a loved one are a wildtype GIST patient, please help the LRG Research Team in its search for the cure by donating your tissue.
Clarence Charles “Buddy” Coats Jr., 65, of Jeffersonville, Indiana, died Sunday, April 22, 2012, at his home. He was buried in Walnut Ridge Cemetery. He was born June 3, 1946, to the late Bud and [...]
Every year, the Life Raft Group’s financial statements are audited, providing a glimpse into the priorities of the organization. Audited results for 2012 will be received soon.
My name is Juliana Popova and I’m the chairperson of the Bulgarian support group for people with GIST – “GIST Alliance for Patients-Bulgaria”. Our organization was founded in January 2012. All patients can contact us [...]
Piga Fernandez, the LRG’s global relations coordinator, participated in an activity called “I have cancer, …lets talk” organized by Red Chile Cancer, a coalition of cancer patient groups in Chile. The main objective [...]
Carol Heller will be working with Jeff Bernstein to cover the state of Pennsylvania as local group leaders. She is very excited to help and hold meetings, and will be handling the eastern region of [...]
First report of a GIST patient responding to a BRAF inhibitor. Dr. Gerald Falchook and colleagues at MD Anderson Cancer Center provided the first report of a GIST patient responding to a BRAF inhibitor. The BRAF gene is frequently mutated in melanoma and BRAF inhibitors provide one of the most important therapies available for melanoma patients
